Pharmaceutical company Moderna said on Tuesday that its coronavirus vaccine was found to be safe and effective on children aged between 12 and 17.
In its phase 2/3 trial, the company evaluated the vaccine on 3,732 participants. Two-third of them were given the vaccine while one-third got a placebo, Moderna said in a statement. The company was aiming to produce an immune response similar to that seen during the large trials in adults, where the vaccine was found to be 94.1% effective at preventing Covid-19.
During the trial on the children, the researchers found out that the vaccine was 100% effective 14 days after receiving the second dose, according to the company’s case definition used in the adult trial. The statement said that after two doses of the vaccine, no cases were reported in the children, while the participants who were administered placebo had four cases of the infection.
However, the vaccine was found to be 93% effective, based on the United States’…
